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Summary.-Nineteen benign human breast tumours, from 19 premenopausal
patients, were processed into slices and each tumour was individually cultured for
2 days in Medium 199. The effects of bovine insulin (5-0 ,ug/ml) human placental
lactogen (10-0 jig/ml) and human growth hormone (10.0 ,ug/ml) on 3H-thymidine
incorporation into DNA were determined on the cultured tumour slices. Insulin and
human placental lactogen significantly (P < 0.01) increased the mean incorporation
of [3H]TdR into DNA, whereas human growth hormone was ineffective. These results
provide evidence that insulin and human placental lactogen, but not human growth
hormone, may be important factors in the aetiology of benign human breast tumours.
IN a recent report, we provided evidence
that both insulin and human placental
lactogen (HPL) were mitogenic to the
ductal epithelium in benign human breast
tumours (Welsch and McManus, 1977).
The mitogenic activity of these peptides
was assessed in vitro by measuring DNA
synthesis of 2-day organ cultures of
freshly biopsied benign breast dysplasias.
Both peptides increased: (1) the
incorporation of [3H]TdR into chemically
extracted DNA, (2) the [3H]TdR auto-
radiographic labelling index and (3) the
mitotic index of these dysplasias, sug-
gesting that one or both of these peptides
may play a role in the aetiology of this
disease.
Human growth hormone (HGH) is a
pituitary peptide, chemically, immuno-
logically and physiologically similar to
HPL (Forsyth, 1974; Bewley and Li,
1974; Handwerger and Sherwood, 1974).
The pituitary peptide has been reported
to have lactogenic and mammary growth-
promoting activities in lower animals
(Forsyth, 1974;HandwergerandSherwood,
1974) but its effect on growth and differen-
tiation of human breast tissues is not
known. Because of the close structural
similarities of HGH and HPL, it was of
interest to determine whether or not
HGH has mitogenic activities toward
benign human breast tumours, as has
been reported for HPL (Welsch and
McManus, 1977).
MATERIALS AND METHODS
Nineteen human benign breast-tumour
biopsy specimens, obtained from 19 pre-
menopausal patients, were placed in a chilled
holdingmediumandreturnedtothelaboratory
within one hour. The biopsy specimens were
immediately and carefully trimmed ofadipose
tissue while immersed in the holding medium.
All tissue preparations were performed in
a laminar-flow hood under aseptic conditions.
Preparation of slices for organ culture.-
Slices of biopsy specimens were prepared with
the aid of a Stadie-Riggs tissue slicer. Each
biopsy specimen provided 5-15 large slices
ranging from 10-15 mm in diameter and
0-10-3 mm in thickness. Each slice was pro-
cessed by a series of halvings with a surgical
blade (i.e., each half was successively halved
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until the slices measured l 1 x 1 mm). The
small slices (1 X 1 mm) were pooled and
placed in 10 x 35 mm Falcon disposable
Petri dishes, 10 slices/dish. Each Petri dish
contained 2-0 ml ofthe culture medium.
Each biopsy specimen was divided into
either 3 or 4 groups (i.e., a control and either
2 or 3 experimental groups). Each group
(controls and experimental) had 9 small
Petri dishes containing a total of 90 small
slices. The small Petri dishes were placed in a
covered water-saturated larger Falcon dis-
posable Petri dish (15 x 100 mm), 3 small
dishes per larger dish. The Petri dishes were
then placed in a small gassing chamber and
housed in an incubator at 37°C. The chambers
were continuously infused with gas (95%
02-5% C02) during the culture period.
All biopsy specimens were individually cul-
tured; slices from different specimens were
never combined. The largenumber ofrandom-
ly selected small slices per group provides
reasonable assurance that an equal quantity
ofepithelium is distributed among the groups
at the onset of culture.
The culture medium used in these studies
was Medium 199, modified Earle's salts
obtained from Grand Island Biological Co.,
Grand Island, NY. The hormones used in
this study, and their concentrations in the
culture media were: bovine pancreas insulin
(California Biochemical Corp., La Jolla,
CA, 22-5 i.u./mg) (5.0 ,g/ml); human
placental lactogen (HPL, Nutritional Bio-
chemical Corp., Cleveland, OH) (10-0 ,ug/ml);
human growth hormone (HGH, NIH-
HS2160E) (10.0 ,tg/ml) and HGH (California
Biochemical Corp, La Jolla, CA) 10-0 Vg/ml.
All media contained gentamicin (Schering
Corp., Kenilworth, NJ) (50 0 itg/ml). After
all additions, the media were passed through
a Millipore filter (0 45 ,um), added to the
Petri dishes, and the entire culture assembly
was frozen ( - 20°C) until the biopsy speci-
mens were brought to the laboratory.
At the end of the 2nd day of culture, 4 h
before termination, sterile methyl-[3H]TdR
(New England Nuclear, Boston, MA; 2-0
Ci/mmol) was added to the culture medium,
at 1-0 ,uCi/ml. Termination of the cultures
was designed to facilitate quick removal
of the small slices from the media (in order
to obtain a wet weight for each group) and
then storage in 0-9% NaCl at -20°C until
DNA extraction and analysis.
DNA extraction and analysis of cultured
slices.-For DNA extraction and analysis,
the tissues from each group were ground in
0-9% NaCl solution with a Willems Polytron
homogenizer. An equal volume of 20%
trichloracetic acid was added to the homo-
genate the resulting precipitate was centri-
fuged (3000 g) and washed twice with 10%
trichloracetic acid. The precipitate was then
washed twice in sodium acetate in methanol
and in chloroform-methanol, once in 100%
ethanol and once in 100% ethyl ether, in
that order, to remove lipid and H20. In all
the foregoing procedures, the preparations
were kept constantly cold. The defatted-de-
hydrated extract was placed in a ventilated
fume hood (12-18 h), then in a vacuum
desiccator (24 h) and was subsequently
weighed.
The defatted-dehydrated extract was diges-
ted (3 h at 37°C) with repeated stirrings in
0-3N KOH. The preparation was cooled,
precipitated with cold 10% perchloric acid,
centrifuged (3000 g) and washed twice. The
precipitate was then incubated for 30 min
with constant stirring in hot (70°C) 5%
perchloric acid in which the DNA was
soluible. This preparation was cooled, centri-
fuged (3000 g) and washed twice with cold
5% perchloric acid. The supernatant was
collected for DNA and [3H]TdR analysis.
DNA content was quantitatively determined
(in duplicate) by the diphenylamine-colori-
metric method of Burton (1956). Calfthymus
DNA (Sigma Chemical Co., St. Louis, MO)
was used as a standard. The [3H]TdR content
was determined by pipetting aliquots (in
triplicate) of the supernatant into modified
Bray's scintillation fluid. The samples were
counted in a Beckman LS-100c liquid scintil-
lation counter with a counting efficiency of
51%. The results were expressed as ct/min
[3H]TdR per ,ug DNA. Significance of
differences between mean ct/min/,ug DNA
values of each group was analysed by the
t test for paired observations.
RESULTS
The addition of insulin or HPL to
culture medium containing explants of
benign human breast tumours signifi-
cantly (P < 0 01) increased the mean
incorporation of[3H]TdR into DNA (Figs.
1 and 2). The addition of a commercially
prepared HGH (HGH-2) or that prepared
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FIG. 1. Effects of insulin and human growth
hormone (HGH) on [3H]TdR incorporation
into DNA of 2-day organ cultures of 10
benign human breast tumours. Control
vs insulin, P < 0-01. Control vs HGH, not
significant.
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FIG. 2. Effects of human placental lactogen
(HPL) and human placental lactogen plus
human growth hormone (HGH) on
[3H]TdR incorporation into DNA of 2-day
organ cultures of 9 benign huiman breast
tumours. Control i's HPL or HPL -+
HGH, P < 0-01. HPL vs HPL HGH,
not significant.
by the U.S. National Institutes of Health
(HGH-1) did not significantly influence
the mean incorporation of the isotope into
DNA (Fig. 1) nor did the pituitary
peptide, in combination with HPL, en-
hance the mitogenic action ofthe placental
peptide (Fig. 2). All 19 breast-tumour
explants actively incorporated [3H]TdR
into DNA during organ culture, to a
level comparable to that previously repor-
ted by our laboratory (Welsch and
McManus, 1977). Nearly all the benign
tumours were classified histologically as
fibrocystic disease with varying degrees
of adenosis and ductal hyperplasia. No
correlation betweenhistopathologicaldiag-
nosis and response to hormones was seen.
DISCUSSION
Unlike malignant human breast tissue,
normal or benign human breast tissue
can be consistently and effectively main-
tained in short-term organ culture (Welsch
et al., 1976; Welsch and McManus, 1977).
This provides a unique opportunity to
study a variety offactors influential in the
development, growth and differentiation
of the human breast. DNA synthesis of
tissue in vitro can be reliably assessed by
the addition of a pulse label of [3H]TdR
4 h before termination of culture. We have
previouslyreported (Welsch andMcManus,
1977) that this method of quantitating
DNA synthesis provides datawhichdirectly
correlates with [3H]TdR labelling indices
and mitotic figure analysis (i.e., when
[3H]TdR incorporation into chemically
extracted DNA is increased, invariably
the [3H]TdR labelling index and mitotic
figure index are similarly increased). Thus
the procedure for assessing DNA synthesis
used in this study has the advantage of
being time saving yet still retains the
precision for measuring mitotic activity.
Although we have previously reported
that insulin and HPL are stimulatory to
DNA synthesis of organ cultures ofbenign
human breast tumours (Welsch and
McManus, 1977) neither our laboratory,
nor others, has previously investigated
whether or not HGH is mitogenic to
these tissues. Whereas we could again
demonstrate a stimulatory effect of insulin
and HPL on these dysplasias, purified
HGH from 2 independent sources did not
show a significant stimulatory effect.
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Both HPL and HGH are single-chain
peptides of 190 amino-acid residues with
2 interchain disulphide bonds (Bewley and
Li, 1.974). The amino-acid compositions
of the 2 hormones are very similar, the
only major differences being in the number
of methionine, histidine and proline resi-
dues. The 2 hormones are identical at
163 of the 190 residues, accounting for
8600 homology in the amino-acid
sequences. Despite this structural simi-
larity, the somatotrophic and lactogenic
activities of these peptides in lower
animals are not always parallel. In com-
paring the lactogenic activities of HPL
and HGH, the lactogenic potency of HPL
is essentially identical to HGH when
measured by the pigeon-crop assay, the
pseudopregnant rabbit mammary intra-
ductal assay or the mid-pregnant mouse
mammary organ culture assay (Forsyth,
1974; Handwerger and Sherwood, 1974).
The pigeon assay uses mucosa-cell
proliferation as an end point, the rabbit
assay uses milk production as an end
point and the mouse assay uses alveolar-
cell proliferation and milk production as
end points. In general, both peptides have
slight but significant stimulatory effects
in the pigeon crop assay and substantial
stimulatory effects in the intraductal and
organ-culture assays. Thus both peptides
in lower animals appear to be not only
lactogenic but mammotrophic as well. In
comparing the general somatotrophic
activities of the 2 peptides, it is apparent
that the 2 hormones have very different
growth-promoting potencies, despite their
structural similarities. Li (1972) has repor-
ted that HPL has 13% of the activity of
HGH in the rodent tibia test and it is
generally agreed that the general growth-
promoting potency of HPL in man is
minimal (McGarry and Beck, 1972).
Despite the close chemical and physio-
logical similarities of HPL and HGH,
there appears to be a marked difference
between them in their ability to stimulate
DNA synthesis of benign human breast
tumours. This observation is important,
because it may provide insight into the
structural entity of HPL prerequisite for
human mammotrophic activities, a site
that may not be analogous to that for
lower animals for which both HPL and
HGH appear to be mammotrophic.
HPL has been reported to stimulate
growth of precancerous mammary-gland
dysplasias in mice (Yanai and Nagasawa,
1973). Whether or not human benign
breast dysplasias are precancerous remains
to be determined, although patients bear-
ing such dysplasias are in an increased
breast-cancer risk group (MacMahon and
Cole, 1973). Prolactin, a pituitary peptide
structurally similar to HPL, is an impor-
tant hormone in murine mammary
tumorigenesis, whereas purfied growth
hormone has not been definitively shown
to be mammary oncogenic in loweranimals
(Welsch and Nagasawa, 1977). The results
presented in this study provide evidence
that HPL (but not HGH) may be an
important hormonal factor in the etiology
of benign disease of the human breast.
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